The resourcing decision : Full-service, FSP or specialist. Which one actually fits your programme?

A decision tree for one of the most overlooked calls in clinical research: which resourcing model actually fits your programme.

Full-service, FSP and specialist resourcing are not different tiers of the same service. They solve different problems, and confusing them is how sponsors end up with the wrong governance structure or the wrong contract discovered six months into a programme.

Our Strategic Resourcing Solutions team built a simple decision tree to cut through that: one question on speed versus control, a second on the kind of gap you are resourcing for. The guide walks through both, with real examples of the requests that signal each model.

What’s inside:

  • A two-question framework for matching the model to the moment
  • Clear definitions of full-service, FSP and specialist resourcing
  • The failure patterns that show up when the wrong model gets chosen
  • 12 questions to ask any resourcing partner before you commit

Learn more about our related services and resources:

TFS Strategic Resourcing Solutions

Download the full guide

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Strategic Resourcing Solutions

Customisation, partnerships and AI the keys to the future of clinical trials
From Strategy to Patients: Adaptability and Innovation in Trial DesignArticle

From Strategy to Patients: Adaptability and Innovation in Trial Design

Explore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.
Functional-Service-Provider-FSP-Models-A-Strategic-Imperative-for-Modern-Clinical-Development_featured
Functional Service Provider (FSP) Models: A Strategic Imperative for Modern Clinical DevelopmentArticle

Functional Service Provider (FSP) Models: A Strategic Imperative for Modern Clinical Development

Discover how the FSP model enhances trial agility, oversight, and scalability, providing a strategic advantage in 2025 clinical development.
How Strategic Resourcing Accelerates Biotech's Path from Preclinical to FIH
Bridging the Gap: How Strategic Resourcing Accelerates Biotech’s Path from Preclinical to FIHArticle

Bridging the Gap: How Strategic Resourcing Accelerates Biotech’s Path from Preclinical to FIH

Discover how strategic resourcing empower biotech startups to navigate early clinical development challenges efficiently.